Analytical method validation demonstrates that a procedure is fit for its intended purpose. Verification confirms that a laboratory can perform an established procedure acceptably under its own conditions. Method transfer provides documented evidence that a receiving laboratory can execute a procedure originating elsewhere.
These activities overlap, but the labels are not interchangeable. The right scope depends on the method's source, the product matrix, the reportable result, and how the result will be used.
Intended purpose comes before the validation list
A method is not “validated” in the abstract. It is validated for a defined analyte, matrix, range, procedure, instrument context, and decision.
An HPLC procedure suitable for identifying a main peptide peak may not be suitable for quantifying a 0.05% impurity. A mass-spectrometry method adequate for confirming nominal intact mass may not quantify variant abundance. A water method used for one lyophilized matrix may suffer interference in another.
The analytical target profile should describe what is measured, in which sample, over what range, with what performance needed for the decision.
Full validation builds evidence for a new or changed procedure
Validation studies commonly address performance characteristics such as:
- specificity or selectivity;
- response and calibration model;
- range;
- accuracy;
- repeatability and intermediate precision;
- detection and quantitation limits;
- robustness;
- stability of samples, standards, and prepared solutions.
Not every characteristic applies in the same way to every procedure. An identity test does not need a quantitative calibration range, while a trace-impurity method requires special attention to sensitivity and recovery.
ICH Q2(R2) organizes validation around the procedure's intended purpose rather than a universal checklist.
Verification applies an established procedure locally
A compendial procedure or a well-established transferred method already has a body of validation evidence. The receiving laboratory still needs to show it can achieve appropriate performance with its analysts, instruments, reagents, environment, and sample matrix.
Verification scope is risk-based. It can include system suitability, specificity in the actual product, precision, accuracy or recovery, and performance near the specification.
Simply running a standard and obtaining the expected retention time does not verify a quantitative method.
A compendial method is not automatically suitable for every product
Pharmacopeial chapters can describe official procedures, but product matrix and sample preparation remain important. The user must verify suitability under actual conditions. Interference, extraction, solubility, concentration, or instrument configuration may differ from the examples assumed by the chapter.
If a laboratory changes an official procedure beyond permitted adjustments, additional validation may be required. The nature and effect of the change, not the fact that the chapter number remains in the report, determine the evidence needed.
Method transfer asks whether performance travels
Transfer can use comparative testing between sending and receiving laboratories, co-validation, partial or full revalidation, or a justified transfer waiver.
A protocol should define samples, analysts, replicates, acceptance criteria, statistical evaluation, deviations, and what prior knowledge is transferred. Hidden details, column conditioning, integration conventions, reagent preparation, instrument settings, often determine whether a written method works.
Training and controlled documents are part of transfer, not substitutes for performance data.
Specificity is tested against plausible interference
A blank shows whether the diluent produces a signal. It does not establish specificity against process impurities, degradants, related peptides, counterions, excipients, or matrix components.
Forced-degradation or spiking studies can challenge whether an assay separates or distinguishes relevant species. The stress conditions should generate informative change without destroying the sample so extensively that unrealistic artifacts dominate.
Peak-purity software can support chromatographic assessment but does not prove that a peak contains one compound. Orthogonal detection may be needed.
Accuracy needs a defensible reference value
Accuracy compares measured results with an accepted value. Spiking known analyte into matrix, analyzing a certified reference, comparing with an independent method, or performing mass balance can provide evidence.
For impurities unavailable as standards, accuracy may rely on surrogate response factors or relative response assumptions. Those limitations should appear in the report.
High spike recovery in a simple buffer does not demonstrate extraction recovery from the actual material.
Precision has layers
Repeatability assesses variation under the same conditions over a short interval. Intermediate precision intentionally varies factors such as day, analyst, instrument, column, or reagent lot within a laboratory. Reproducibility addresses variation between laboratories.
Many reported “precision” studies consist only of repeated injections from one prepared vial. That measures injection repeatability, not the variability of sample preparation or the full procedure.
Independent preparations are needed when preparation contributes to the result.
Robustness is planned variation, not accidental survival
Robustness studies vary parameters likely to drift during normal use: flow rate, temperature, pH, extraction time, reagent concentration, or column lot. The ranges should reflect realistic control capability and scientific risk.
Design-of-experiments approaches can reveal interactions between parameters more efficiently than changing one factor at a time. Findings can establish method controls and system-suitability criteria.
An excursion outside validated ranges is a deviation to assess, not evidence of robustness by default.
Lifecycle monitoring continues after validation
Method performance can change as instruments age, columns change, reference standards are replaced, software is updated, or the product process evolves. Trending system suitability, control samples, invalid runs, out-of-specification results, and transfer performance can reveal drift.
Revalidation or partial revalidation may be needed after meaningful changes to procedure, matrix, range, instrument technology, manufacturing process, or specification.
Validation is therefore a lifecycle, not a binder completed once.
What a complete validation summary should show
Look for:
- intended purpose and reportable result;
- analyte, matrix, range, and specification;
- controlled procedure version;
- predefined performance criteria;
- study design and independent preparations;
- raw and summarized results;
- deviations and failed runs;
- statistical methods;
- conclusion tied to each claim;
- ongoing controls and change triggers.
“Method validated” without scope and results is a status statement, not evidence a reader can evaluate.
Bottom line
Validation establishes fitness for a specified analytical purpose. Verification confirms suitable local performance of an established procedure. Transfer demonstrates that performance can move between laboratories. Clear intended use and risk determine how much evidence each activity needs.
Sources
- International Council for Harmonisation. Q2(R2): Validation of Analytical Procedures.
- International Council for Harmonisation. Q14: Analytical Procedure Development.
- U.S. Food and Drug Administration. Analytical Procedures and Methods Validation for Drugs and Biologics.
- United States Pharmacopeia. General Chapter <1225> Validation of Compendial Procedures.
- United States Pharmacopeia. General Chapter <1226> Verification of Compendial Procedures.
Continue reading
Editorial responsibility and corrections
Published by Serum Research. Sources checked October 1, 2026. This is educational material; no independent scientific, clinical, statistical, analytical, or regulatory review is claimed. Read how we review evidence or send a correction.
For Research Use Only. Not for Human Consumption. This page does not provide instructions for medical use or establish the identity, quality, safety, or equivalence of a catalog material.